Genmab A/S (GMAB)

NMS – Цена в реальном времени. Валюта: USD

31.41

+0.56 (1.82%)

При закрытии: Aug 12, 2026, 3:59 PM EDT

31.42

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:00 PM EDT

11.08.2026

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the Company or others.

07.08.2026

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

06.08.2026

Genmab A/S Q2 Earnings Call Highlights

Genmab A/S NASDAQ: GMAB reported first-half 2026 revenue growth of 25% year over year and raised its full-year financial outlook, citing continued momentum from DARZALEX, EPKINLY and the broader portfolio. The company also outlined upcoming late-stage trial readouts and announced two new Phase III studies of petosemtamab in colorectal cancer.

Видео

No Data

There is no data to display

Пресс-релизы

11.08.2026

Genmab A/S (GMAB)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Genmab A/S (GMAB)

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Search stocks

Genmab A/S (GMAB)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Genmab A/S (GMAB)

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Видео

No Data

Пресс-релизы

Capital Increase in Genmab as a Result of Employee Warrant Exercise